Lumentum Trades Below Marvell’s Buyout Offer. Is the Gap a Bargain?
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Lumentum (NASDAQ:LITE | LITE Price Prediction) is posting rapid revenue growth. Its stock, however, now trades on two forces outside its control: the share price of Marvell Technology (NASDAQ:MRVL) and the risk that the two companies’ merger falls apart. At Marvell’s latest price of $168.80, the all-stock offer means $759.60 per Lumentum share. Lumentum last changed hands at $648.06. That leaves a gap of about 17.2%.
How a Fixed Exchange Ratio Moves the Offer
TIKR reported that Marvell agreed on November 2 to buy Lumentum for a fixed 4.5 Marvell shares per Lumentum share. The ratio never changes, so every swing in Marvell’s stock flows straight into the offer’s dollar value. TIKR said that at the October 28 reference prices, the deal was worth about $1,132 per Lumentum share, a 23.9% premium. The AI hardware selloff then hit both stocks. Since October 12, Marvell has fallen 38.7% and Lumentum has dropped 37.2%.
The difference between the offer’s value and the target’s price is called a merger arbitrage spread. Buyers of Lumentum have to wait for the deal to close, and they also carry the risk that it never does. The spread pays them for both. Longer timelines and bigger risks produce wider spreads.
Regulators and Time Explain the Discount
TIKR reported that the deal needs several regulatory approvals, including China’s, and is not expected to close until the first half of 2028. That ties up capital for a long time. Meanwhile, Lumentum shares have slipped since the deal was announced.
TIKR also reported that Marvell owes Lumentum a $3.2 billion fee if the deal fails on regulatory grounds. That money would go to Lumentum’s balance sheet. Shareholders would be left with a standalone stock priced on its own fundamentals, which could be well below the offer value.
Strong Fundamentals Keep Building Under the Deal
Lumentum’s fiscal first-quarter 2027 revenue reached $1.26 billion, up 136.5% year over year. For the December quarter, the company guided to revenue of $1.575 billion to $1.625 billion. Non-GAAP gross margin expanded to 53.2% from 39.4% a year earlier.
Near- and co-packaged optics place optical engines right beside AI processors, so data travels as light instead of over copper. It is the kind of picks-and-shovels AI expansion story we covered beyond the chipmakers in a free report on seven suppliers powering the data-center boom.
Chief Executive Officer Michael Hurlston said in the earnings release:
During the quarter, we secured our second major NPO/CPO win, backed by purchase commitments exceeding $5 billion. Additionally, our OCS demand visibility has expanded significantly in recent months, positioning optical switching to become a multi-billion-dollar annual revenue stream.
For comparison, Coherent (NYSE:COHR), a larger optical peer, grew fiscal first-quarter revenue 49.9% to $2.37 billion with a 40.6% non-GAAP gross margin. Coherent CEO Jim Anderson said, “AI datacenters transition from copper to optical connectivity.” Lumentum is growing faster than Coherent and earning a higher gross margin.
Bernstein Trims Its Target but Stays Bullish
Bernstein cut its Lumentum price target to $635 from $900 and kept its Outperform rating, before later raising it to $700. The latest target lands above Lumentum’s current price but below the offer’s implied value of $759.60.
Who Actually Benefits From the Spread
A Lumentum holder who waits for the deal to close ends up owning Marvell stock. That makes the 17.2% gap most relevant to investors comfortable owning Marvell for years. If Marvell’s stock keeps falling, the payout shrinks with it. For investors who want Lumentum’s optics growth without Marvell exposure, the spread carries a trade-off, because closing swaps that exposure away.
Two events will test the spread. The first is Marvell’s next earnings report, scheduled for December 1, 2026, after the market close. The second is any regulatory ruling on the deal, especially from China. A weak Marvell report would cut the offer’s value, and a regulatory setback would likely widen the gap.
Contact [email protected] for any questions or corrections.








